Abstract
Background and objectiveAs a chronic inflammatory disease of an unknown origin, the treatment of granulomatous mastitis has always been controversial. According to some researchers, surgical treatment and certain medications, especially steroids, are more effective in treating the disease. This study aimed at evaluating the results of treatment in a group of patients with granulomatous mastitis.Materials and methodsThis longitudinal cohort study evaluated the treatment outcomes of 87 patients with pathology-confirmed granulomatous mastitis referred to the surgical clinic of Central Hospital in Sari, Iran. Demographic, clinical, and pathological information, treatment methods and results, and the recurrence rate were analyzed.FindingsA total of 87 female patients with granulomatous mastitis aged 22–52 years with a mean age of 34 years were evaluated. All patients had palpable masses; the breast masses were painful in 48.3% of patients, and 55.2% of patients suffered from erythema and inflammation, and8% had fistulas and ulcers at the inflammation site. The patients were followed-up for an average duration of 26 months (8–48 months) after treatment and recovery. The overall recurrence rate was 24.1%, and the recurrence rate was 29.4% in patients underwent surgery, 34.8% in patients received high-dose prednisolone, and 17% in those received low-dose prednisolone together with drainage (p < 0.001).ConclusionsAccording to the results, the low-dose prednisolone plus drainage was more effective with a lower recurrence rate than only surgical excision or high-dose prednisolone. In fact, the use of minimally invasive methods such as drainage plus low-dose steroids is a more effective method with fewer side effects than the other two methods.
Highlights
Idiopathic granulomatous mastitis (IGM) is a chronic benign inflammatory disease of the breast that often affects women of reproductive age [1]
According to the results, the low-dose prednisolone plus drainage was more effective with a lower recurrence rate than only surgical excision or high-dose prednisolone
This study aims at investigating the outcomes of treatment in three groups of patients with IGM
Summary
Idiopathic granulomatous mastitis (IGM) is a chronic benign inflammatory disease of the breast that often affects women of reproductive age [1]. Corticosteroids and surgical excision are known as current treatments [2, 7,8,9,10]. Surgical treatment of IGM includes local abscess drainage and wide excision or mastectomy. Methotrexate treatment is usually not common in the treatment of Shojaee et al BMC Surg (2021) 21:206 patients with idiopathic granulomatous mastitis and is mostly used in cases resistant to common therapies with side effects of corticosteroids and has been associated with good results in this group of patients [11]. As a chronic inflammatory disease of an unknown origin, the treatment of granulomatous mastitis has always been controversial. Surgical treatment and certain medications, especially steroids, are more effective in treating the disease. This study aimed at evaluating the results of treatment in a group of patients with granulomatous mastitis
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
